SYNJECTOS® is a member of SYNJECTOS GROUP with headquater in Vietnam and foreignprivately-owned in Vietnam establish company.

The company is incorporated in 2017.

Synjectos® develops and manufactures a Calcium Phosphate Cement designed to restore and substitute bone.

Synjectos® is used in all areas of Traumatology and Orthopaedics that deals with bone loss during surgery and/or after trauma. Typical indications are filling of bone cysts, articular depression fractures in spine and long bones or filling of defects after autologous bone harvesting.


Our bespoke design, development and manufacturing processes allow us to control all production stages, thus guaranteeing the highest quality, from raw materials right to the finished product.


Synjectos® has been patented and obtained significant product quality certifications

Thanks to our working philosophy, we have tried to explain the needs of our patients, making them breakthrough products, asserting ourselves as a leader in the global medical device market.

advisory boards


Ralf Uwe Rößler is a German chemist, dentist and university lecturer with a focus on teaching and research in periodontology and implantology. Rößler is the founder and dean of the University for Digital Technologies in Medicine & Dentistry, DTMD, in Luxembourg.

Univ.-Prof. Prof. h.c. Dr. Dr. Dr. h.c. Reinhard Schnettler

Research Group Leader, Tissue Engineering / antimicrobial allografts and biomaterials, UKE Hamburg, Department for Oral and Maxillofacial Surgery